Aroxim

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aroxim

Quick Facts

Property Description
Active ingredient Cefixime Trihydrate (Cefixime)
Form Tablets, Capsules, Granules, Suspension
Pharmacological class Third-Generation Cephalosporin Antibiotic
Common use Combating bacterial infections
Origin Synthetic Compound

What Type of Medicine is Aroxim (Cefixime)?

Aroxim is a prescription-only medicine containing the active ingredient Cefixime (INN), which is chemically classified as a Third-Generation Cephalosporin Antibiotic. This classification establishes Aroxim as a key component of the beta-Lactam antibiotic family, specifically used to combat susceptible bacterial infections. Cefixime is utilized across clinical practice to address a wide range of bacterial pathogens. This means the drug's primary function is to serve as an effective tool for microbial elimination in scenarios like respiratory or urinary tract infections.

Composition, Origin, and Available Forms

The active substance, Cefixime, is a synthetic compound manufactured chemically, not derived from a natural source. Aroxim is a single-active-ingredient product formulated exclusively for Oral Administration. It is available in various dosage form(s), including tablets, capsules, and oral suspensions. The availability of liquid forms, such as Granules for Oral Suspension, allows for flexible administration, particularly in pediatric patient groups who may struggle with solid medication.

General Therapeutic Purpose and Mechanism Summary

The general therapeutic purpose of Aroxim is to eliminate specific bacterial organisms that cause infection through its potent bactericidal effect. This action is achieved by interfering with the integrity of the bacterial structure, specifically through the Inhibition of Cell Wall Synthesis. By disrupting this essential building process, Cefixime causes the microbes to rupture and die, effectively clearing the underlying bacterial threat and supporting the patient's recovery.

Regulatory References

  1. Cefixime Drug Information

What side effects are possible with Aroxim?

Possible Side Effects and Safety Information

The official regulatory safety profile for Aroxim (Cefixime) classifies potential adverse reactions based on frequency and the physiological system affected. Adverse reactions are grouped using standard frequency tiers, where those documented as Very Common or Common are generally related to the gastrointestinal system.

The most frequent adverse event documented in official labels is diarrhea, often noted alongside other common gastrointestinal disorders such as loose stools, abdominal pain, nausea, vomiting, and dyspepsia. Other less common reactions reported include headache, dizziness, and transient elevations in liver enzymes.

Serious Safety Considerations

Official prescribing information highlights several serious adverse reactions that are potentially life-threatening but may occur rarely or with an unknown frequency. These include severe hypersensitivity reactions (e.g., anaphylaxis, including shock) and rare, severe skin disorders, known as Severe Cutaneous Adverse Reactions (SCARs), such as Stevens–Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The drug is also associated with acute organ injury, including reports of acute renal failure and forms of hepatitis or cholestatic jaundice.

Population-Specific Safety Notes

The official label includes specific constraints for certain populations. Caution is required in patients with markedly impaired renal function (Creatinine clearance below 20 ml/min) due to slower drug clearance, which increases the risk for adverse effects, notably encephalopathy. Additionally, patients with a history of penicillin allergy are noted as having a risk of cross-allergenicity, and safety has not been established in infants younger than six months of age. Prolonged use carries the risk of overgrowth of non-susceptible organisms.

Overdose and Emergency Response

Overdose and When to Seek Help

The following information details the officially documented manifestations and regulatory requirements for Cefixime (Aroxim) overdose, as specified in government regulatory documents.


Documented Overdose Manifestations

Overdose with Aroxim is primarily documented to involve Central Nervous System (CNS) effects due to exposure to very high doses. These officially listed manifestations include encephalopathy, convulsions (seizures), and hyperreflexia. The neurological symptoms are noted in regulatory labeling as potentially reversible upon drug elimination. Accompanying effects may include general gastrointestinal disturbances such as nausea, vomiting, and diarrhea.


Required Emergency Actions

In the event of a suspected overdose, immediate medical attention must be sought. Management is defined as symptomatic and supportive treatment, as regulatory documents explicitly state that no specific antidote is known for Cefixime overdose. Interventions such as gastric lavage may be indicated based on clinical assessment.

Official prescribing information also notes that Cefixime is not removed in significant quantities by hemodialysis or peritoneal dialysis, limiting the use of these procedures in overdose management.


Population-Specific Consideration

Regulatory documentation highlights that patients with impaired renal function may experience elevated and prolonged plasma concentrations of the medicine. This condition can potentially increase the risk or severity of the documented CNS toxic effects.

Therapeutic Uses of Aroxim

Aroxim plays a role in managing infections that are associated with susceptible bacterial organisms, which contributes to the overall management of acute symptoms. The focus of the therapy is on managing pronounced symptomatic episodes that can create noticeable physiological strain. The drug is indicated for several common conditions, offering symptomatic relief that may help patients cope more steadily.

This medicine is commonly used across conditions presenting with acute episodes, including those of the respiratory tract (such as pharyngitis, tonsillitis, sinusitis, and acute bronchitis), the ear (otitis media), and the urinary tract (uncomplicated UTIs and pyelonephritis). It is also relevant for managing certain conditions characterized by periods of heightened symptoms, such as Typhoid Fever and Shigellosis.

“The supportive action is applied in situations involving certain distressing symptoms, notably pain, fever, and discomfort.”

Addressing Symptom Domains

Aroxim is relevant in clinical settings marked by infections of the urinary, respiratory, and enteric tracts. It helps address groups of symptoms that may appear suddenly, such as pain and burning during urination or sore throat and cough. The supportive action helps ease the overall symptom burden, which contributes to improved day-to-day comfort during these acute phases and assists with maintaining functional stability.

Quick Fact: Relief for Symptomatic Discomfort

Category Typical Symptoms Addressed
Respiratory Sore throat, cough, chest discomfort, sinus pressure
Systemic High fever, general malaise
Urological Burning during urination (dysuria), localized pain

Regulatory References

  1. NIH DailyMed Prescribing Information

Eligibility and Restrictions for Use

Who can and cannot use Aroxim?


Contraindicated Populations

Aroxim is strictly contraindicated for individuals with a known hypersensitivity or allergy to Cefixime, any other cephalosporin antibiotic, or a history of severe hypersensitivity reaction to beta-lactam antibacterial agents such as penicillins. The medicine must not be used by these groups under any circumstance.


Age and Renal Function Eligibility

Population Regulatory Status
Infants (< 6 months) Safety and effectiveness not established; use is not recommended.
Children, Adolescents, Adults Established for use in patients aged six months and older.
Renal Impairment Restricted use; eligible patients with creatinine clearance less than 60 mL/min require dose adjustment.

Specific Conditional Use and Restrictions

Use of Aroxim requires caution in patients with a history of penicillin allergy, as well as those with a history of gastrointestinal diseases, particularly colitis, or certain bleeding problems. For pregnant women, use is restricted and should occur only if clearly needed. Official labeling advises that breastfeeding mothers should consider temporarily discontinuing nursing during treatment.

What should I know about interactions with other medicines?

Aroxim Interactions with other medicines and products

Aroxim (Cefixime) interactions are defined by officially documented patterns that impact certain co-administered medicinal products and diagnostic procedures. No medicinal combinations are formally categorized as absolutely contraindicated in official regulatory labeling.

Interactions Affecting Co-administered Medicines

Interacting Substance Official Interaction Pattern Outcome as Stated by Regulator
Oral Anticoagulants (e.g., Warfarin) Associated with a fall in prothrombin activity. May result in an increased prothrombin time (INR), raising the potential for hemorrhage.
Carbamazepine Co-administration reported in postmarketing surveillance. Results in elevated Carbamazepine levels (increased drug exposure).

The official profile notes that the anticoagulant interaction may pose a higher risk in specific patient populations. Individuals with renal impairment, hepatic impairment, a poor nutritional state, or those already stabilized on anticoagulant therapy are identified as being at increased risk.

Drug-Substance and Food Interactions

Administration of Cefixime tablets or suspension does not significantly affect the overall absorption or peak plasma concentration when taken with food. However, Cefixime is reported to cause a false positive reaction when used with tests employing nitroprusside reagents for the detection of urinary ketones.

Mechanism of Action

️ Irreversible Inhibition of Cell Wall Synthesis

Aroxim operates as an irreversible inhibitor by targeting essential bacterial enzymes known as Penicillin-Binding Proteins (PBPs), particularly PBP-3. These enzymes are crucial for the final cross-linking of the microbe's structural component, the peptidoglycan layer. By binding to the PBPs, the drug prevents this cross-linking step, which compromises the structural integrity of the bacterial cell wall.

Activation of the Bactericidal Lysis Cascade

The inhibition of cell wall construction initiates a lethal cascade. The weakened bacterial wall is unable to withstand the high internal osmotic pressure, leading to the physical rupture of the cell—a process called lysis. This actively bactericidal effect results in the irreversible death of the microorganism, achieving the wholesale destruction of the microbe.

Understanding Mechanism Limitations

The drug’s mechanism is constrained by bacterial countermeasures, such as the production of β-Lactamase enzymes, which hydrolyze and neutralize the active part of the Cefixime molecule before it can reach the PBPs. Additionally, structural modifications to the PBPs themselves can reduce the drug's binding affinity, functionally limiting the mechanism's effectiveness against certain strains.

Dosage and Administration Information

How to Use Aroxim: Official Administration Guidelines

The usage of Aroxim (Cefixime) is governed by specific instructions which dictate the authorized route, dosage, frequency, and duration of the medicine. Aroxim is formulated exclusively for Oral Administration. It is available as tablets, capsules, and granules for oral suspension, allowing for varied administration methods depending on patient needs.


Standard Dosing and Frequency

For most adult use patterns, the standard dosage is 400 mg administered once daily. This 400 mg dose may also be divided into 200 mg taken every 12 hours. The specific duration of the treatment course typically ranges between 7 to 14 days, which is determined by the condition being addressed.


Administration Context and Special Conditions

Administration Factor Official Instruction
Timing Relative to Meals May be taken with or without food
Suspension Preparation Granules must be reconstituted with water and shaken well prior to administration
Pediatric Dosing Dosing is weight-based, typically 8 mg/kg daily
Dose Adjustment Rule Dose modification is required for patients with renal impairment where creatinine clearance is below 60 mL/min

These instructions define the standardized approach for using Aroxim. The entire prescribed course must be completed, and if a dose is missed, it should be taken as soon as it is remembered unless the next dose is imminent.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aroxim


Evidence for Use in Common Infections

The primary research for Aroxim was evaluated for common infections characterized by acute episodes. For Uncomplicated Urinary Tract Infections (UTIs), studies involved Randomized Controlled Trials (RCTs) and Systematic Reviews that included other established antimicrobial agents as comparators. These trials mainly monitored two things: microbial findings and outcomes related to physical discomfort (such as pain or burning during urination). Findings describe patterns observed in the studies related to microbial findings and how symptoms changed over time in the observed populations.

For Pharyngitis and Tonsillitis, studies were also conducted in the form of RCTs, often using other established therapies as comparators. Research examined outcomes related to systemic findings, such as the eradication of the specific Streptococcus bacteria and how patients reported their experience. Research provides context but not individual predictions regarding short-term symptom changes.


Research on Otitis Media and Respiratory Tract Conditions

For Otitis Media (middle ear infection), the evidence base consists of Randomized Controlled Trials and Comparative Trials conducted in pediatric populations. These studies monitored outcomes related to physical discomfort and systemic findings. Findings describing patterns in the speed and degree of symptom change were measured over the observation period, but variability in reported outcomes was observed depending on the specific pathogen involved.

For Acute Exacerbations of Chronic Bronchitis (AECB), research involved comparative clinical trials focused on adults experiencing periods of heightened symptom activity. Studies monitored outcomes related to physical discomfort and systemic imbalance, such as the reduction in cardinal respiratory symptoms. Data show patterns related to these outcomes.


What Is Still Uncertain About the Research

Research highlights what is known, but evidence also indicates several areas of ongoing uncertainty. Follow-up durations were limited in many studies, meaning long-term effects are not fully established. While studies exist, data for certain groups remain insufficient. Due to the continuous evolution of antimicrobial resistance, evidence derived from settings with varying symptom burdens remains important. Findings describe group patterns, not personal outcomes, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Cefixime: MedlinePlus Drug Information (US National Library of Medicine)

Frequently Asked Questions (FAQ)

Common questions about Aroxim (FAQ)


Q: What is Aroxim used for besides the main condition?

According to the official product information, Aroxim is approved to treat several infections beyond the most common ones. It is described as addressing bacterial infections in the urinary tract, the ear (otitis media), the throat (pharyngitis and tonsillitis), the lungs (acute exacerbations of bronchitis), and certain forms of uncomplicated gonorrhea. Regulatory documents outline these specific therapeutic uses.

Q: How long does it take for Aroxim to leave the body?

Official pharmacokinetic studies indicate how quickly the medicine is cleared from the body. The elimination half-life of Cefixime, the drug's active ingredient, is approximately 3 to 4 hours. This measure describes the time required for the concentration of the medicine in the blood to decrease by half.

Q: Is Aroxim known to affect sleep?

Official adverse event reporting includes less common effects related to the central nervous system. Drowsiness has been reported as an adverse reaction. Patients who experience changes in alertness are usually advised to consider this effect before performing complex tasks.

Q: Can Aroxim change my appetite?

Official regulatory documents list changes in appetite as a potential, though not guaranteed, side effect. Loss of appetite (anorexia) has been reported as a less common event in clinical reports for this medicine. Other common gastrointestinal side effects are also described in the safety profile.

Q: What foods or drinks should I avoid while using Aroxim?

Official labeling states that Aroxim can be taken with or without food, meaning its absorption is not significantly affected by meals. Regulatory information generally does not specify avoidance of individual common foods. However, the official documentation does not address all possible interactions with specific foods, beverages, or herbal products.

Q: Is Aroxim safe for people over 65?

Official information notes that clinical studies did not include enough subjects aged 65 and older to establish distinct differences in how they respond compared to younger subjects. The response patterns of elderly and younger patients have generally not identified differences, though specific factors like reduced kidney function in elderly patients are noted as requiring consideration.

Q: Is there a different way to take Aroxim if I have liver issues?

For patients with cirrhosis (a form of chronic liver disease), official pharmacokinetic studies indicate that dosage adjustment is not generally required. However, the time it takes for the drug to be eliminated from the body may be longer in these patients, which is a consideration described in the labeling.

Q: Is Aroxim generally considered safe for long-term use?

The medicine is typically prescribed for a short course (e.g., 7 to 14 days). Official warnings state that prolonged use of Aroxim carries the risk of the overgrowth of non-susceptible organisms, which is a factor that influences the typically short prescribed duration.

Q: Why is Aroxim sometimes only prescribed for a short time?

The short duration of the prescription is described in official guidelines for antimicrobial stewardship. The purpose of this duration is to reduce the development of drug-resistant bacteria and to minimize the risk of overgrowth of other non-susceptible organisms within the body, a strategy outlined in the official prescribing information.

Q: Are there different strengths of Aroxim available?

Yes, Aroxim is available in various forms as indicated in the official prescribing information. The product is supplied in different strengths, typically including 400 mg capsules. For liquid forms, oral suspension concentrations such as 100 mg/5 mL and 200 mg/5 mL are commonly available, allowing for flexible administration, especially for pediatric patients.

Q: Why is it important to complete the full course of Aroxim?

Official usage guidelines emphasize the completion of the full prescribed course. The rationale for this approach is that it helps to reduce the development of drug-resistant bacteria and is described as maintaining the overall effectiveness of antibacterial treatments. This aligns with standard principles of antimicrobial use.

Q: What should I do if I get an allergic reaction to Aroxim?

Official regulatory documents indicate that if signs of an allergic reaction or severe side effects occur (such as a rash, swelling, or trouble breathing), the medicine should be stopped and immediate medical attention is warranted. This is due to the risk of severe hypersensitivity events described in the safety profile.

Q: Does Aroxim have a Black Box Warning?

The official U.S. Prescribing Information for Cefixime (the active ingredient in Aroxim) does not contain a Black Box Warning. This type of warning is the highest level of caution required by the FDA to call attention to serious or life-threatening risks associated with a medicine.

Q: Why is Aroxim considered a prescription-only medicine?

Aroxim is designated as a prescription-only medicine because, as an antibacterial drug, its use is intended only for infections proven or strongly suspected to be caused by bacteria. This determination requires medical diagnosis and is a part of the strategy to support the long-term stewardship of the medicine.

Q: Is it safe to drive while taking Aroxim?

Official safety data indicates that dizziness has been reported as a side effect. Therefore, patients who experience this effect are usually advised in official labeling to use caution when driving or operating heavy machinery until the medicine's effects on concentration and balance are known.

Q: Is Aroxim affected by alcohol consumption?

The official regulatory labeling does not specify an interaction or contraindication with alcohol consumption for Aroxim. As with all medications, any concurrent consumption of alcohol should be a consideration.

How should Aroxim be stored and disposed of?

Aroxim (Cefixime) must be stored and disposed of according to specific official regulatory guidelines to maintain stability and ensure safety.

Storage Requirements

Dosage Form Temperature and Protection Stability Constraint
Tablets Store below 25 C or 30 C. Protect from light, moisture, and excessive heat. Store in original, tightly closed container.
Liquid Suspension Store reconstituted liquid at room temperature or refrigerated (2 C to 8 C), depending on the label. Do not freeze. Discard any unused portion after 7 or 14 days of reconstitution.

All forms of the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Aroxim must be disposed of properly. Regulatory instructions state that the medicine should not be flushed down the toilet or thrown into household trash. Consult a pharmacist or utilize a local medicine take-back program for instructions on discarding the unused product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aroxim found in:

A-Z Index: